- 专利标题： INSULIN CONTAINING PHARMACEUTICAL COMPOSITIONS
-
申请号： EP20208962.9申请日： 2017-12-15
-
公开(公告)号： EP3821905A1公开(公告)日： 2021-05-19
- 发明人: NORRMAN, Mathias , HOSTRUP, Susanne , STEENSGAARD, Dorte Bjerre , STRAUSS, Holger Martin , HANSEN, Rosa Rebecca Erritzøe , HAVELUND, Svend , SCHLEIN, Morten , PEDERSEN, Jesper Søndergaard
- 申请人： Novo Nordisk A/S
- 申请人地址： DK 2880 Bagsværd Novo Allé
- 优先权： EP16204688 20161216
- 主分类号： A61K38/28
- IPC分类号： A61K38/28 ; A61K38/26 ; A61K47/02 ; A61K9/00 ; A61P5/48
摘要：
The present invention is in the field of pharmaceutical compositions for the treatment of medical conditions relating to diabetes. More specifically the invention provides pharmaceutical compositions comprising a long-acting acylated derivative of a human insulin analogue and semaglutide, and to the medical use of such compositions for basal insulin administration therapy.
公开/授权文献
- EP3821905B1 INSULIN CONTAINING PHARMACEUTICAL COMPOSITIONS 公开/授权日：2022-10-12
信息查询
IPC分类:
